While Insiders Own 26% of Zhejiang Longsheng Group Co.,Ltd (SHSE:600352), Individual Investors Are Its Largest Shareholders With 56% Ownership

Key Insights Zhejiang Longsheng GroupLtd's significant individual investors ownership suggests that the key decisions are influenced by shareholders from the larger public A total of 25 investors ha

Simply Wall StJun 20 01:04 ET

Zhejiang Yonghe Refrigerant (SHSE:605020) Might Be Having Difficulty Using Its Capital Effectively

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for? One common approach is to try and find a company with returns on capital employed

Simply Wall StJun 19 23:17 ET

At CN¥152, Is Zhejiang Cfmoto Power Co.,Ltd (SHSE:603129) Worth Looking At Closely?

Zhejiang Cfmoto Power Co.,Ltd (SHSE:603129), is not the largest company out there, but it saw a significant share price rise of 38% in the past couple of months on the SHSE. While good news for

Simply Wall StJun 19 22:33 ET

Returns On Capital At Zhejiang Provincial New Energy Investment Group (SHSE:600032) Have Hit The Brakes

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Amongst other things, we'll want to see two things; firstly, a growing return on capital employe

Simply Wall StJun 19 21:54 ET

Pinning Down Zhejiang Hisoar Pharmaceutical Co., Ltd.'s (SZSE:002099) P/S Is Difficult Right Now

When you see that almost half of the companies in the Pharmaceuticals industry in China have price-to-sales ratios (or "P/S") below 3.1x, Zhejiang Hisoar Pharmaceutical Co., Ltd. (SZSE:002099) looks t

Simply Wall StJun 19 21:53 ET

Is There An Opportunity With Zhejiang Huahai Pharmaceutical Co., Ltd.'s (SHSE:600521) 47% Undervaluation?

Key Insights Zhejiang Huahai Pharmaceutical's estimated fair value is CN¥32.64 based on 2 Stage Free Cash Flow to Equity Current share price of CN¥17.25 suggests Zhejiang Huahai Pharmaceutical is po

Simply Wall StJun 19 20:55 ET